Data di Pubblicazione:
2024
Citazione:
The contribution of genetics and epigenetics to MAFLD susceptibility / V. Moretti, S. Romeo, L. Valenti. - In: HEPATOLOGY INTERNATIONAL. - ISSN 1936-0533. - 18:2 supp(2024 Oct), pp. 848-860. [10.1007/s12072-024-10667-5]
Abstract:
Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common liver disease worldwide. The risk of developing MAFLD varies among individuals, due to a combination of environmental inherited and acquired genetic factors. Genome-wide association and next-generation sequencing studies are leading to the discovery of the common and rare genetic determinants of MAFLD. Thanks to the great advances in genomic technologies and bioinformatics analysis, genetic and epigenetic factors involved in the disease can be used to develop genetic risk scores specific for liver-related complications, which can improve risk stratification. Genetic and epigenetic factors lead to the identification of specific sub-phenotypes of MAFLD, and predict the individual response to a pharmacological therapy. Moreover, the variant transcripts and protein themselves represent new therapeutic targets. This review will discuss the current status of research into genetic as well as epigenetic modifiers of MAFLD development and progression.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Epigenetic factors; GWAS; MAFLD; Next-generation sequencing; Therapeutic targets;
Elenco autori:
V. Moretti, S. Romeo, L. Valenti
Link alla scheda completa:
Link al Full Text: